Skip to content
OpenCapital
Get started

BioAmber BIOA Q4 2024 Annual earnings

Reported March 20, 2025 · Before market open

Diluted EPS-$1.97Miss by $1.39
Revenue estimate$556.7K
EPS estimate-$0.58

Next report

Aug 5, 2026 (In 3 weeks)
Revenue estimate$1.5M
EPS estimate-$0.65

Versus estimates

Revenue

Q1 2026$2.8MBeat by $1.7MQ4 2025$3.1MBeat by $1.7MQ3 2025$2.1MBeat by $914.0KQ2 2025$2.4MBeat by $1.5MQ1 2025$1.5MBeat by $871.0K

Diluted EPS

Q1 2026-$0.52Beat by $0.12Q4 2025-$0.72Beat by $0.11Q3 2025-$0.56Beat by $0.11Q2 2025-$0.60Miss by $0.04Q1 2025-$0.36Beat by $0.16
Q4 2024-$1.97Miss by $1.39

Ask the moment BioAmber reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did BioAmber report Q4 2024 earnings?
BioAmber (BIOA) reported Q4 2024 earnings on March 20, 2025 before market open.
What were BioAmber's Q4 2024 revenue and EPS?
BioAmber reported diluted EPS of $-1.97 for Q4 2024.
Did BioAmber beat estimates in Q4 2024?
EPS missed the consensus estimate of $-0.58 by $1.39.
Where can I find BioAmber's Q4 2024 SEC filings?
You can read the 10-K periodic report (0000950170-25-042759) directly on SEC EDGAR. The filing index links above go to sec.gov.